These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19928588)

  • 1. [The role of apolipoproteins A-I and A-II in plasma HDL remodeling].
    Wróblewska M
    Postepy Biochem; 2009; 55(3):315-22. PubMed ID: 19928588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
    Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
    Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W; Chen J; Redinger RN
    J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.
    Fiévet C; Igau B; Bresson R; Drouin P; Fruchart JC
    Diabete Metab; 1995 Apr; 21(2):95-8. PubMed ID: 7621978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular processing of HDL by the liver during reverse cholesterol transport.
    Mayes PA; Mindham MA
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():147-8. PubMed ID: 8767494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
    Tailleux A; Duriez P; Fruchart JC; Clavey V
    Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique role of apolipoprotein A-I in HDL remodeling and metabolism.
    Pownall HJ; Ehnholm C
    Curr Opin Lipidol; 2006 Jun; 17(3):209-13. PubMed ID: 16680023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
    Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
    Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
    Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
    J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
    Carreón-Torres E; Rendón-Sauer K; Monter-Garrido M; Toledo-Ibelles P; Gamboa R; Menjivar M; López-Marure R; Luc G; Fievet C; Cruz D; Vargas-Alarcón G; Pérez-Méndez O
    Clin Chim Acta; 2009 Mar; 401(1-2):37-41. PubMed ID: 19036342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.
    Gillard BK; Lin HY; Massey JB; Pownall HJ
    Biochim Biophys Acta; 2009 Dec; 1791(12):1125-32. PubMed ID: 19635584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction.
    Luc G; Majd Z; Poulain P; Elkhalil L; Fruchart JC
    Atherosclerosis; 1996 Nov; 127(1):131-7. PubMed ID: 9006813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of smoking cessation on serum apolipoprotein A-I and A-II concentrations.
    Masarei JR; Puddey IB; Vandongen R; Beilin LJ; Lynch WJ
    Pathology; 1991 Apr; 23(2):98-102. PubMed ID: 1745574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes.
    Bassett GR; Gillard BK; Pownall HJ
    Biochemistry; 2012 Oct; 51(43):8627-35. PubMed ID: 23025327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
    Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
    Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.